Cargando…
Direct-Acting Antivirals in Chronic Hepatitis C Genotype 4 Infection in Community Care Setting
BACKGROUND: Limited data exists comparing the safety, tolerability, and efficacy of direct-acting antivirals (DAAs) in patients with chronic hepatitis C genotype 4 (HCV GT-4) in the community practice setting. We aim to evaluate the treatment response of DAAs in these patients. METHODS: All the HCV...
Autores principales: | Gayam, Vijay, Khalid, Mazin, Mandal, Amrendra Kumar, Hussain, Muhammad Rajib, Mukhtar, Osama, Gill, Arshpal, Garlapati, Pavani, Shrestha, Binav, Guss, Debra, Sherigar, Jagannath, Mansour, Mohammed, Mohanty, Smruti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916637/ https://www.ncbi.nlm.nih.gov/pubmed/29707080 http://dx.doi.org/10.14740/gr999w |
Ejemplares similares
-
Association Between Vitamin D Levels and Treatment Response to Direct-Acting Antivirals in Chronic Hepatitis C: A Real-World Study
por: Gayam, Vijay, et al.
Publicado: (2018) -
Sofosbuvir based regimens in the treatment of chronic hepatitis C genotype 1 infection in African–American patients: a community-based retrospective cohort study
por: Gayam, Vijay, et al.
Publicado: (2018) -
Real-World Clinical Efficacy and Tolerability of Direct-Acting Antivirals in Hepatitis C Monoinfection Compared to Hepatitis C/Human Immunodeficiency Virus Coinfection in a Community Care Setting
por: Gayam, Vijay, et al.
Publicado: (2018) -
Rectourethral Fistula Secondary to Transurethral Resection of the Prostate
por: Gayam, Vijay, et al.
Publicado: (2018) -
Drug-Induced Liver Injury: An Institutional Case Series and Review of Literature
por: Gayam, Vijay, et al.
Publicado: (2018)